Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir(R) therapy: A case report.
No Thumbnail Available
Date
2020-05-22
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Primary malignant melanoma of the uterine cervix is a rare disease with poor prognosis and high recurrence rate. We used Rigvir® as adjuvant therapy for a stage IVA patient. Tolerability, overall and progression-free survival are good.
Description
Keywords
ECHO-7 virus, melanoma, oncology, oncolytic virus, Rigvir, uterine cervix